Your browser doesn't support javascript.
loading
The Efficacy of Vitamin C on Postoperative Outcomes after Posterior Lumbar Interbody Fusion: A Randomized, Placebo-Controlled Trial.
Lee, Gun Woo; Yang, Han Seok; Yeom, Jin S; Ahn, Myun-Whan.
Afiliação
  • Lee GW; Spine Center and Department of Orthopaedic Surgery, Yeungnam University Medical Center, Daegu, Korea.
  • Yang HS; Spine Center and Department of Orthopaedic Surgery, Yeungnam University Medical Center, Daegu, Korea.
  • Yeom JS; Spine Center and Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Ahn MW; Spine Center and Department of Orthopaedic Surgery, Yeungnam University Medical Center, Daegu, Korea.
Clin Orthop Surg ; 9(3): 317-324, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28861199
ABSTRACT

BACKGROUND:

Vitamin C has critical features relavant to postoperative pain management and functional improvement; however, no study has yet evaluated the effectiveness of vitamin C on improving the surgical outcomes for spine pathologies. Thus, this study aimed to explore the impact of vitamin C on postoperative outcomes after single-level posterior lumbar interbody fusion (PLIF) for lumbar spinal stenosis in prospectively randomized design. We conducted a 1-year prospective, randomized, placebo-controlled, double-blind study to evaluate the impact of vitamin C on the postoperative outcomes after PLIF surgery.

METHODS:

A total of 123 eligible patients were randomly assigned to either group A (62 patients with vitamin C) or group B (61 patients with placebo). Patient follow-up was continued for at least 1 year after surgery. The primary outcome measure was pain intensity in the lower back using a visual analogue scale. The secondary outcome measures were (1) the clinical outcome assessed using the Oswestry Disability Index (ODI); (2) the fusion rate assessed using dynamic radiographs and computed tomography scans; and (3) complications.

RESULTS:

Pain intensity in the lower back was significantly improved in both groups compared with preoperative pain intensity, but no significant difference was observed between the 2 groups over the follow-up period. The ODI score of group A at the third postoperative month was significantly higher than the score of group B. After the sixth postoperative month, the ODI score of group A was slightly higher than the score of group B; however, this difference was not significant. The fusion rates at 1 year after surgery and the complication rates were not significantly different between the 2 groups.

CONCLUSIONS:

Postoperative pain intensity, the primary outcome measure, was not significantly different at 1 year after surgery between the 2 groups. However, vitamin C may be associated with improving functional status after PLIF surgery, especially during the first 3 postoperative months.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Fusão Vertebral / Vitaminas / Vértebras Lombares Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Fusão Vertebral / Vitaminas / Vértebras Lombares Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article